RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shandong Wohua Pharmaceutical Co Stock

Shandong Wohua Pharmaceutical Co EBIT 2024

Shandong Wohua Pharmaceutical Co EBIT

51.3 M CNY

Ticker

002107.SZ

ISIN

CNE000001QB8

In 2024, Shandong Wohua Pharmaceutical Co's EBIT was 51.3 M CNY, a -51.39% increase from the 105.52 M CNY EBIT recorded in the previous year.

The Shandong Wohua Pharmaceutical Co EBIT history

YEAREBIT (undefined CNY)
202351.3
2022105.52
2021204.1
2020211.7
2019105.9
201846.5
2017106.4
201660.8
201571.7
201433.6
20130.1
2012-3.8
2011-2.5
2010-105.4
200936.4
200867.3
200741.9
200640.6
200537.6
200436.2

Shandong Wohua Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shandong Wohua Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shandong Wohua Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shandong Wohua Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shandong Wohua Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shandong Wohua Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shandong Wohua Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shandong Wohua Pharmaceutical Co’s growth potential.

Shandong Wohua Pharmaceutical Co Revenue, EBIT and net profit per share

DateShandong Wohua Pharmaceutical Co RevenueShandong Wohua Pharmaceutical Co EBITShandong Wohua Pharmaceutical Co Net Income
2023909.51 M undefined51.3 M undefined58.77 M undefined
20221.01 B undefined105.52 M undefined107.39 M undefined
2021942.7 M undefined204.1 M undefined163.4 M undefined
20201.01 B undefined211.7 M undefined178.9 M undefined
2019860.3 M undefined105.9 M undefined95.8 M undefined
2018774.4 M undefined46.5 M undefined45.7 M undefined
2017726.6 M undefined106.4 M undefined57 M undefined
2016562.8 M undefined60.8 M undefined48.8 M undefined
2015468.9 M undefined71.7 M undefined71.4 M undefined
2014437.9 M undefined33.6 M undefined43.3 M undefined
2013255.6 M undefined100,000 undefined10.6 M undefined
2012209.6 M undefined-3.8 M undefined8.3 M undefined
2011149 M undefined-2.5 M undefined7.4 M undefined
201090.9 M undefined-105.4 M undefined-97.8 M undefined
2009172.2 M undefined36.4 M undefined52.4 M undefined
2008192.4 M undefined67.3 M undefined51.8 M undefined
2007129.4 M undefined41.9 M undefined35.4 M undefined
2006123 M undefined40.6 M undefined32 M undefined
2005111.3 M undefined37.6 M undefined28.4 M undefined
200491.4 M undefined36.2 M undefined23.1 M undefined

Shandong Wohua Pharmaceutical Co stock margins

The Shandong Wohua Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shandong Wohua Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shandong Wohua Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shandong Wohua Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Shandong Wohua Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shandong Wohua Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shandong Wohua Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shandong Wohua Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shandong Wohua Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shandong Wohua Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shandong Wohua Pharmaceutical Co Margin History

Shandong Wohua Pharmaceutical Co Gross marginShandong Wohua Pharmaceutical Co Profit marginShandong Wohua Pharmaceutical Co EBIT marginShandong Wohua Pharmaceutical Co Profit margin
202374.19 %5.64 %6.46 %
202274.85 %10.4 %10.58 %
202177.19 %21.65 %17.33 %
202077.51 %21.04 %17.78 %
201976.26 %12.31 %11.14 %
201876.9 %6 %5.9 %
201778.41 %14.64 %7.84 %
201674.63 %10.8 %8.67 %
201572.21 %15.29 %15.23 %
201468.81 %7.67 %9.89 %
201378.21 %0.04 %4.15 %
201278.05 %-1.81 %3.96 %
201176.78 %-1.68 %4.97 %
201071.4 %-115.95 %-107.59 %
200974.74 %21.14 %30.43 %
200863.98 %34.98 %26.92 %
200778.28 %32.38 %27.36 %
200679.67 %33.01 %26.02 %
200579.96 %33.78 %25.52 %
200478.45 %39.61 %25.27 %

Shandong Wohua Pharmaceutical Co Aktienanalyse

What does Shandong Wohua Pharmaceutical Co do?

Shandong Wohua Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Shandong Wohua Pharmaceutical Co's EBIT

Shandong Wohua Pharmaceutical Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Shandong Wohua Pharmaceutical Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Shandong Wohua Pharmaceutical Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Shandong Wohua Pharmaceutical Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Shandong Wohua Pharmaceutical Co stock

How much did Shandong Wohua Pharmaceutical Co achieve in EBIT for the current year?

In the current year, Shandong Wohua Pharmaceutical Co has achieved an EBIT of 51.3 M CNY.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Shandong Wohua Pharmaceutical Co.

How has the EBIT of Shandong Wohua Pharmaceutical Co developed in recent years?

The EBIT of Shandong Wohua Pharmaceutical Co has increased by -51.385% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Shandong Wohua Pharmaceutical Co?

The EBIT of Shandong Wohua Pharmaceutical Co is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Shandong Wohua Pharmaceutical Co pay?

Over the past 12 months, Shandong Wohua Pharmaceutical Co paid a dividend of 0.26 CNY . This corresponds to a dividend yield of about 6.09 %. For the coming 12 months, Shandong Wohua Pharmaceutical Co is expected to pay a dividend of 0.26 CNY.

What is the dividend yield of Shandong Wohua Pharmaceutical Co?

The current dividend yield of Shandong Wohua Pharmaceutical Co is 6.09 %.

When does Shandong Wohua Pharmaceutical Co pay dividends?

Shandong Wohua Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of June, May, April, June.

How secure is the dividend of Shandong Wohua Pharmaceutical Co?

Shandong Wohua Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Shandong Wohua Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0.26 CNY are expected. This corresponds to a dividend yield of 6.09 %.

In which sector is Shandong Wohua Pharmaceutical Co located?

Shandong Wohua Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shandong Wohua Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shandong Wohua Pharmaceutical Co from 5/24/2024 amounting to 0.25 CNY, you needed to have the stock in your portfolio before the ex-date on 5/24/2024.

When did Shandong Wohua Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 5/24/2024.

What was the dividend of Shandong Wohua Pharmaceutical Co in the year 2023?

In the year 2023, Shandong Wohua Pharmaceutical Co distributed 0.26 CNY as dividends.

In which currency does Shandong Wohua Pharmaceutical Co pay out the dividend?

The dividends of Shandong Wohua Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shandong Wohua Pharmaceutical Co

Our stock analysis for Shandong Wohua Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shandong Wohua Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.